Floating matrix tablets of atenolol: Formulation and in vitro evaluation

VD Havaldar, AS Kulkarni, RJ Dias, NH Aloorkar, KK Mali


The purpose of the study was to prolong the gastric residence time of atenolol by designing its floating tablets and to study the influence of different polymers on its release rate. Nine formulations of atenolol containing varying concentrations of polymers were designed by optimization. The floating matrix tablets of atenolol were prepared by direct compression method. The prepared tablets were evaluated for physicochemical parameters such as hardness,
floating properties (floating lag time, floating time and matrix integrity), swelling studies  and drug content. The physicochemical parameters of formulated tablets were found to be within normal range. A significant difference in drug
release (P , 0.0001) and floating lag time (P , 0.005) at 0.5, one, four and eight hours were observed. The floating lag time of all the formulations was within the prescribed limit (,10 minutes). All the formulations showed good matrix
integrity and retarded the release of drug for eight hours. The release pattern of atenolol was fitted to different models based on coefficient of correlation (r). All the formulations, except F2, F3 and F6 showed Korsemeyer-Peppas model
as the best fit model. Formulation F2 and F3 showed first order model while F6 showed zero order model. Diffusion exponent (n) value was found in the range of 0.52-0.99 indicating diffusion as a release mechanism. The swelling studies
of all the formulations showed that formulations containing Xanthan gum has higher swelling indices than HPMC K100M and HPMC K4M. It can be concluded that formulations with higher swelling indices retarded the release of drugs more
than those with lower swelling indices.

Full Text:



Ichikawa M, Watanake S, Yake YM. A new multiple unit oral floating

dosage systems: Preparation and in vitro evaluation of floating and

sustained release characteristics. J Pharm Sci 1991;80:1062-6.

Yeole PG, Khan S, Shah K. Floating drug delivery system: Need and

development. Int J Pharm Sci 2005;67:265-72.

Chawla G, Gupta P, Koradia V, Bansal AK. Gastro retention, a means to

address regional variability in intestinal drug absorption. Pharm Tech


Davis SS. Formulation strategies for absorption windows. DDT


Arora S, Ali J, Ahuja A, Khar RK, Baboota S. Floating drug delivery

system. AAPS Pharm Sci Tech 2005;6:E372-90.

Rocca JG, Omidian H, Shah K. Progress in gastro retentive drug delivery

system, Business Briefing: PharmaTech 2003;5:152-6

Talukdar MM, Mooter GV, Augustijns P, Tjandra-Maga T, Verbeke N,

Kinget R. In vivo evaluation of xanthan gum as potential excipients for oral

controlled release matrix tablet formulation. Int J Pharm 1998;169:105-13.

Choi BY, Park HJ, Hawng SJ, Park JB. Preparation of alginate beads for

floating drug delivery system: Effect of CO2 gas forming agents. Int J

Pharm 2002;239:81-91.

Sungthongjeen S, Paeratakul O, Limmatvapirat S. Preparation and in vivo evaluation of a multiple unit floating drug delivery system based on

gas formation technique. Int J Pharm 2006;324:136-43.

Shimpi S, Chauhan B, Mahadik KR, Paradkar A. Preparation and

evaluation of diltiazem hydrochloride-gelucire 43/01 floating granules

prepared by melt granulation. AAPS Pharm Sci Tech 2004;5:1-6.

Tanwar YS. Floating microspheres: Development, characterization and

application. Available from: http://www.pharmainfo.net. [last cited in 2007].

Dollery C. Therapeutic Drugs.1st ed. Edinburgh: Churchill Livingstone;

p. A.224-7.

Florey K. Analytical profile of drug substances. 12th ed. Vol. 13.

New Delhi: Reed Elsevier India Pvt. Ltd; 2005. p. 2-25.

Chopra S, Patil GV, Motwani SK. Release modulating hydrophilic matrix

systems of losartan potassium: Optimization of formulation using

statistical experimental design. Eur J Pharm Biopharm 2007;66:73-82.

Srivastava AK, Wadhwa S, Ridhurkar D. Oral sustained delivery

of atenolol from floating matrix tablets- Formulation and in vitro

evaluation. Drug Dev Ind Pharm 2005;31:367-74.

Siepmann J, Peppas NA. Modeling of drug release from delivery systems

based on hydroxy propyl methyl cellulose (HPMC). Adv Drug Deli Rev


Costa P, Lobo JM. Modeling and comparison of dissolution profiles. Eur

J Pharm Sci 2001;13:123-33.

Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol


Babu PS, Devi MV, Sankar KM. In vitro evaluation of commercial modified

release glipizide tablets. The Indian Pharmacist 2004;3:65-9

Vendruscolo CW, Andreazza IF, Ganter JL, Ferrero C, Bresolin TM.

Xanthan and galactomann (From M. Scabrella) matrix tablets based for

oral controlled delivery of theophylline. Int J Pharm 2005;296:1-11.

Banker GS, Anderson NR. Tablets. The Theory and Practice of Industrial

Pharmacy. 3rd ed. Bombay: Varghese Publishing House; 1998. p. 297-9.

Rahman Z, Ali M, Khar RK. Design and evaluation of bilayer floating

tablets of captopril. Acta Pharma 2006;56:49-57.

Hiremath SN, Farhat F, Swamy PV, Ramanamurthy KN. Design and in vitro

evaluation of hydrodynamically balanced system of famotidine. Ind Dru


Missaghi S, Fisshi R. Release characterization of dimenhydrate from

an eroding and swelling matrix: Selection of appropriate dissolution

apparatus. Int J Pharm 2005;293:35-42.

Indian Pharmacopoeia. Vol. 1. New Delhi: Controller of Publications;

: p. 74.

Sangalli ME, Maroni A, Foppoli A, Zema L, Giordano F, Gazzaniga A.

Different HPMC viscosity grades as a coating agent for an oral time

and or site controlled delivery system: Study on process parameters

and in vitro performances. Eur J Pharm Sci 2003;22:469-76.

Mirchandani HL, Chien YW, Bruce PD, Senshang L, Shoufeng L. Effect

of HPMC and carbopol on the release and floating properties of

gastric floating drug delivery system using factorial design. Int J Pharm


Jamzad S, Tutunji L, Fisshi R. Analysis of macromolecular changes and

drug release from hydrophilic matrix. Int J Pharm 1999;292:75-85.

DOI: http://dx.doi.org/10.22377/ajp.v3i4.281


  • There are currently no refbacks.